Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Testing Status of Gallium arsenide 11192-E

 

CASRN: 1303-00-0

Formula: As-Ga

Synonyms/Common Names

  • Gallium monoarsenide

Short-Term Toxicity

  • 2 weeks (Inhalation)  (C62033)  Completed 
    • Rats: F344/N; Mice: B6C3F1
    • Dose: R & M: 0, 1, 10, 37, 75 OR 150 MG/M3 (5/S/S).
  • 13 weeks (Inhalation)  (C62033)  Completed 
    • Rats: F344/N; Mice: B6C3F1
    • Dose: R&M:0, 0.1, 1, 10, 37, 75 MG/M3/20 & 10 PER GROUP RESPECTIVELY.

Long-Term Carcinogenicity

  • 2 years (Inhalation)  (C62033B)  Completed 
    • TR-492 (NIH Number: 00-3951)  (Peer Review Approval 05/21/1999A )
      Toxicology and Carcinogenesis Studies of Gallium Arsenide (CASRN 1303-00-0) in F344/N Rats and B6C3F1 Mice (Inhalation Studies)
    • Rats: F344/N; Mice: B6C3F1
    • Carcinogenesis Results
      • Male Rats No Evidence 
      • Female Rats Clear Evidence 
      • Male Mice No Evidence 
      • Female Mice No Evidence 
    • Dose: R: 0, 0.01, 0.1, OR 1.0 MG/M3; 50/SEX/GROUP M: 0, 0.1, 0.5, OR 1.0 MG/M3; 50/SEX/GROUP.

Special Studies

  • Absorption Disposition Metabolism Elimination (Gavage; Intratracheal)  (S0144)  Completed 
    • Citation: Carter DE, Bellamy WT. Toxicology of the group III-V intermetallic semiconductor, gallium arsenide. In: Clarkson TW, Frieberg L, Nordberg GF, and Sager PR, eds. Biological Monitoring of Toxic Metals. Plenum Publishing Corp. 1988:455-468.
    • Male Rats
    • Dose: PO:10, 100, 1000 INTRATRACHEAL:100 MG/KG.
  • Absorption Disposition Metabolism Elimination (Intratracheal)  (S0444)  Completed 
    • Citation: Webb DR, Wilson SE, Carter DE. Comparative pulmonary toxicity of gallium arsenide, gallium(III) oxide, or arsenic(III) oxide intratracheally instilled into rats. Toxicol Appl Pharmacol. 1986 Mar 15;82(3):405-16.Pubmed Abstract
    • Male Rats: F344/N
    • Dose: 100 mg/kg.
  • Absorption Disposition Metabolism Elimination (Gavage; Intratracheal)  (S0445)  Completed 
    • Citation: Webb DR, Sipes IG, Carter DE. In vitro solubility and in vivo toxicity of gallium arsenide. Toxicol Appl Pharmacol. 1984 Oct;76(1):96-104.Pubmed Abstract
    • Male Rats: F344/N
    • Dose: 10, 100, or 1000 mg/kg for gavage. 10, 30, or 100 mg/kg for Intratracheal.
  • Absorption Disposition Metabolism Elimination (Intratracheal)  (S0470)  Completed 
    • Citation: Rosner MH, Carter DE. Metabolism and excretion of gallium arsenide and arsenic oxides by hamsters following intratracheal instillation. Fundam Appl Toxicol. 1987 Nov;9(4):730-7.Pubmed Abstract
    • Male Hamsters: Syrian Golden
  • Absorption Disposition Metabolism Elimination (Gavage; Intratracheal)  (S0766)  Completed 
    • Rats
    • Dose: gavage, 10, 100 or 1000 mg/kg. intratracheal 10, 30, 0r 100 mg/kg.
  • Absorption Disposition Metabolism Elimination (Intratracheal)  (S0767)  Completed 
    • Citation: Webb DR, Wilson SE, Carter DE. Pulmonary clearance and toxicity of respirable gallium arsenide particulates intratracheally instilled into rats. Am Ind Hyg Assoc J. 1987 Jul;48(7):660-7.Pubmed Abstract
    • Male Rats: F344/N
  • Toxicokinetic Study (Inhalation)  (S0564)  Completed 
    • Male and Female Rats: F344/N; Male and Female Mice: B6C3F1
    • Dose: RAT: 0, 0.01, 0.1, & 1.0 MG/M3; MICE: 0, 0.1, 0.5, & 1.0 MG/M3.

Genetic Toxicology

  • Micronucleus  (A56833)  Completed 
    • Citation: Witt, K.L., Knapton, A., Wehr, C.M., Hook, G.J., Mirsalis, J., Shelby, M.D., and MacGregor, J.T. Micronucleated Erythrocyte Frequency in Peripheral Blood of B6C3F1 Mice from Short-Term, Prechronic, and Chronic Studies of the NTP Carcinogenesis Bioassay Program. Environ. Molec. Mutagen. Vol. 36 (2000) 163-194
    • Mice: B6C3F1
    • Male Negative 
    • Female Negative 
  • Salmonella  (006180)  Completed 
    • Citation: Zeiger, E., Anderson, B., Haworth, S., Lawlor, T., and Mortelman, K. Salmonella Mutagenicity Tests V. Results from the Testing of 311 Chemicals Environ. Molec. Mutagen. Vol. 19 (Suppl 21) (1992) 2-141
    •  Negative 

Organ Systems Toxicity

  • Immunotoxicity (Intratracheal)  (IMM90013)  Completed 
    • Female Mice: B6C3F1
    • Mice Female Positive 
    • Dose: 0, 50, 100, 200 MG/KG.
  • 4 to 19 GD Conventional Teratology (Inhalation)  (TER89143)  Completed 
    • Rats: Sprague Dawley
    • Rats Maternal Positive 
    • Rats Fetal Positive 
    • Dose: 0, 10, 37, 75 MG/CUBIC METER.
  • 4 to 17 GD Conventional Teratology (Inhalation)  (TER90043)  Completed 
    • Female Mice: Swiss
    • Mice Maternal Positive 
    • Mice Fetal Positive 
    • Dose: 10, 37, 75 MG/CUBIC METER.